Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A to Z of Drugs : V

Records returned : 37 (on 29 May 2025 at 01:19:56).

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Vacuum erection devices

Drug:

Vacuum erection devices

Indication :

Erectile dysfunction

Status :

Green

Formulations :

Not Specified

Restrictions / Comments:

Important

Treatments for ED on the NHS require an SLS endorsement.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

2. Vacuum erection devices

Drug:

Vacuum erection devices

Indication :

Erectile dysfunction combination therapy

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

3. Vaginal devices for female urinary incontinence

Drug:

Vaginal devices for female urinary incontinence

Indication :

Urinary incontinence

Status :

Blue

Formulations :

Vaginal insert

Restrictions / Comments:

Important

Prescribing in primary care on recommendation from the specialist NHS Pelvic Health Physiotherapy Team only.

DIVEEN - 3rd line - consider if other devices are unsuitable. Efemia is the preferred device.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

4. Vaginal devices for female urinary incontinence

Drug:

Vaginal devices for female urinary incontinence

Indication :

Urinary incontinence

Status :

Blue

Formulations :

Vaginal insert

Restrictions / Comments:

Important

Preferred

Prescribing in primary care on recommendation from the specialist NHS Pelvic Health Physiotherapy Team only.

EFEMIA - 1st line. Reusable product. Preferred choice for daily or intermittent use

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

5. Vaginal devices for female urinary incontinence

Drug:

Vaginal devices for female urinary incontinence

Indication :

Urinary incontinence

Status :

Blue

Formulations :

Vaginal insert

Restrictions / Comments:

Important

Prescribing in primary care on recommendation from the specialist NHS Pelvic Health Physiotherapy Team only.

CONTIFORM - 2nd line choice for daily or intermittent use.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

6. Vaginal devices for female urinary incontinence

Drug:

Vaginal devices for female urinary incontinence

Indication :

Urinary incontinence

Status :

Blue

Formulations :

Vaginal insert

Restrictions / Comments:

Important

Prescribing in primary care on recommendation from the specialist NHS Pelvic Health Physiotherapy Team only.

CONTRELLE ACTIVGARD - not a preferred device. Single-use and more costly than alternatives.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

7. Vaginal moisturisers

Drug:

Vaginal moisturisers

Indication :

Vaginal atrophy

Status :

Non Formulary

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

8. Valaciclovir

Drug:

Valaciclovir

Indication :

Herpes infection

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Follow local guidelines on the use of antimicrobials

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

9. Valganciclovir

Drug:

Valganciclovir

Indication :

Cytomegalovirus

Status :

Red

Formulations :

Oral solution

Restrictions / Comments:

Important

Restricted antimicrobial to be used under advice of Microbiology consultant

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

10. Valsartan

Drug:

Valsartan

Indication :

Heart failure

Status :

Green

Formulations :

Capsules

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

11. Valsartan

Drug:

Valsartan

Indication :

Hypertension

Status :

Green

Formulations :

Capsules

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

12. Valsartan with hydrochlorothiazide

Drug:

Valsartan with hydrochlorothiazide

Indication :

Hypertension

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

MHRA alert: Hydrochlorothiazide risk of non-melanoma skin cancer

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

13. Vancomycin hydrochloride

Drug:

Vancomycin hydrochloride

Indication :

Bacterial infection

Status :

Red

Formulations :

Infusion

Restrictions / Comments:

Important

Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. This drug requires therapeutic monitoring.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

14. Vancomycin hydrochloride

Drug:

Vancomycin hydrochloride

Indication :

Bacterial keratitis / corneal ulcer

Status :

Red

Formulations :

Eye drops (preservative free)

Restrictions / Comments:

Important

5% preservative free eye drops (unlicensed). Under microbiology guidance. Ophthalmology only.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

15. Vancomycin hydrochloride

Drug:

Vancomycin hydrochloride

Indication :

Clostridioides difficile

Status :

Green

Formulations :

Capsules

Restrictions / Comments:

Important

Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. The APC notes that although current NICE guidelines recommend vancomycin first line for treatment of C diff, it is recognised that this was based on cost and in exceptional cases when a liquid is required, fidaxomicin granules are appropriate to prescribe as a licensed preparation that supports timely treatment.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

16. Vancomycin hydrochloride

Drug:

Vancomycin hydrochloride

Indication :

Endophthalmitis

Status :

Red

Formulations :

Intravitreal injection

Restrictions / Comments:

Important

Ophthalmology specialists only.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

17. Vardenafil

Drug:

Vardenafil

Indication :

Benign prostatic hyperplasia

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

18. Vardenafil

Drug:

Vardenafil

Indication :

Erectile dysfunction

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1

19. Vardenafil

Drug:

Vardenafil

Indication :

Erectile dysfunction combination therapy

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

20. Vardenafil

Drug:

Vardenafil

Indication :

Penile rehabilitation

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

21. Varenicline tartrate

Drug:

Varenicline tartrate

Indication :

Smoking cessation

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

22. Vedolizumab

Drug:

Vedolizumab

Indication :

Immunotherapy related colitis

Status :

Red

Formulations :

Intravenous infusion
Subcutaneous injection (sc)

Restrictions / Comments:

Important

Only after steroids and infliximab (1st-line) have been ineffective

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

23. Vedolizumab

Drug:

Vedolizumab

Indication :

Inflammatory bowel disease

Status :

Red

Formulations :

Infusion
Subcutaneous injection (sc)

Restrictions / Comments:

Important

Not 1st line. Only in patients where steroids and/or TNF inhibitor not effective / appropriate

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

ICB

NICE

24. Vedolizumab

Drug:

Vedolizumab

Indication :

Pouchitis

Status :

See narrative

Formulations :

Not Specified

Restrictions / Comments:

Important

This drug, for this indication, has not yet been assessed for formulary status. Contact your pharmacy team for advice on making an application to APC.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD2

25. Venlafaxine

Drug:

Venlafaxine

Indication :

Menopausal disorders

Status :

Green (see narrative)

Formulations :

Modified release tablets

Restrictions / Comments:

Important

Off-label use.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

26. Verapamil hydrochloride

Drug:

Verapamil hydrochloride

Indication :

Angina

Status :

Green

Formulations :

Modified release capsules
Modified release tablets
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

27. Verapamil hydrochloride

Drug:

Verapamil hydrochloride

Indication :

Angina

Status :

Green

Formulations :

Oral solution

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

28. Verapamil hydrochloride

Drug:

Verapamil hydrochloride

Indication :

Arrhythmias

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

29. Verapamil hydrochloride

Drug:

Verapamil hydrochloride

Indication :

Arrhythmias

Status :

Red

Formulations :

Injection

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

30. Vibegron

Drug:

Vibegron

Indication :

Overactive bladder (adults)

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

Mirabegron is the preferred option where an antimuscarinic is not suitable. Vibegron should have a very limited place in therapy.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

31. Vigabatrin

Drug:

Vigabatrin

Indication :

Epilepsy

Status :

Blue

Formulations :

Sachets (powder)
Tablets

Restrictions / Comments:

Important

Specialist initiation before transfer of prescribing to primary care

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

32. Vigabatrin

Drug:

Vigabatrin

Indication :

Epilepsy

Status :

Non Formulary

Formulations :

Soluble tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

33. Vildagliptin

Drug:

Vildagliptin

Indication :

Diabetes Mellitus

Status :

Non Formulary

Formulations :

Tablets

Restrictions / Comments:

Important

Existing patients would not be expected to change therapy unless appropriate to do so.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1

34. Viper antivenom

Drug:

Viper antivenom

Indication :

Envenomation by Vipera Berus

Status :

Red

Formulations :

Intravenous infusion

Restrictions / Comments:

Important

https://www.toxbase.org/ . Unlicensed. Store in the fridge. Can be ordered from Public Health England (PHE) by email vaccinesupply@phe.gov.uk

https://www.toxbase.org/

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

35.

Drug:

Indication :

Vitamin and mineral supplementation

Status :

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

36. Von Willebrand factor

Drug:

Von Willebrand factor

Indication :

Antihaemorrhagic agents

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Important

NHS England - specialist centres only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

NHSE

37. Vonicog alfa

Drug:

Vonicog alfa

Indication :

von Willebrand deficiency

Status :

Red

Formulations :

Not Specified

Restrictions / Comments:

Important

NHS England - specialist centres only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE